James J J, Evans A J, Pinder S E, Gutteridge E, Cheung K L, Chan S, Robertson J F R
Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK.
Br J Cancer. 2003 Aug 18;89(4):660-5. doi: 10.1038/sj.bjc.6601198.
The aim of this study was to identify factors that may be associated with the development of bone metastases in patients with metastatic breast carcinoma and to see if any of these factors had a bearing on subsequent survival. In total, 492 patients presented to the Nottingham City Hospital with metastatic breast carcinoma between July 1997 and December 2001. Of these, 267 patients had bone metastases at presentation with metastatic disease, 91 patients in this group had bone as their only site of metastatic disease. Sites of first presentation of metastatic disease were prospectively recorded, as were histological features of the primary tumour (tumour type, histological grade, lymph node stage, tumour size and oestrogen receptor (ER) status). The radiological features of the bone metastases, the metastasis-free interval and serological tumour marker levels at presentation with metastases were all recorded. There was a significant association between the development of bone metastases and lower grade tumours (P=0.019), ER-positive tumours (P<0.0001) and the lymph node stage of the primary tumour (P=0.047). A multivariate analysis found that metastasis-free interval, additional sites of metastatic disease other than bone, ER status and serological tumour marker levels all independently contributed to survival from time of presentation with bone metastases.
本研究的目的是确定可能与转移性乳腺癌患者骨转移发生相关的因素,并观察这些因素是否对后续生存有影响。1997年7月至2001年12月期间,共有492例转移性乳腺癌患者就诊于诺丁汉市医院。其中,267例患者在出现转移性疾病时已有骨转移,该组中有91例患者骨是转移性疾病的唯一部位。前瞻性记录了转移性疾病的首次出现部位,以及原发肿瘤的组织学特征(肿瘤类型、组织学分级、淋巴结分期、肿瘤大小和雌激素受体(ER)状态)。记录了骨转移的放射学特征、无转移间期以及出现转移时的血清肿瘤标志物水平。骨转移的发生与低级别肿瘤(P = 0.019)、ER阳性肿瘤(P < 0.)、原发肿瘤的淋巴结分期(P = 0.047)之间存在显著关联。多因素分析发现,无转移间期、除骨以外的转移性疾病其他部位、ER状态和血清肿瘤标志物水平均独立影响骨转移出现后的生存情况。